GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Total Inventories

Nortem Biogroup (XPAR:MLBIO) Total Inventories : €4.29 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Total Inventories?

Nortem Biogroup's total inventories for the quarter that ended in Dec. 2023 was €4.29 Mil. Nortem Biogroup's average total inventories from the quarter that ended in Dec. 2022 to the quarter that ended in Dec. 2023 was €4.19 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Nortem Biogroup's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was €-2.58.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Nortem Biogroup's Days Inventory for the six months ended in Dec. 2023 was 1,385.12.

Inventory Turnover measures how fast the company turns over its inventory within a year. Nortem Biogroup's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.13.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Nortem Biogroup's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.58.


Nortem Biogroup Total Inventories Historical Data

The historical data trend for Nortem Biogroup's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup Total Inventories Chart

Nortem Biogroup Annual Data
Trend Dec21 Dec22 Dec23
Total Inventories
2.17 4.09 4.29

Nortem Biogroup Semi-Annual Data
Dec21 Dec22 Dec23
Total Inventories 2.17 4.09 4.29

Nortem Biogroup Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Nortem Biogroup  (XPAR:MLBIO) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Nortem Biogroup's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is

Net-Net Working Capital Per Share (Q: Dec. 2023 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.409+0.75 * 0.106+0.5 * 4.291-9.287
-0-0)/2.5785
=-2.58

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Nortem Biogroup's Days Inventory for the six months ended in Dec. 2023 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2023 )/Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=4.1895/0.552*365 / 2
=1,385.12

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Nortem Biogroup's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2023 ) / Average Total Inventories (Q: Dec. 2023 )
=0.552 / 4.1895
=0.13

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Nortem Biogroup's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=4.1895 / 7.198
=0.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Nortem Biogroup Total Inventories Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Nortem Biogroup Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500
Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup Headlines

No Headlines